Co-Diagnostics, Inc. — Director's Dealing 2018

Oct 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2018-10-05

Reporting Person: Egan Dwight H (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-05	Non-Qualified Stock Option (right to buy)	$2.75	A	150000	Acquired	2023-10-05	Common stock (150000)	Direct

Footnotes

F1: The stock option will vest on the basis determined by the equity incentive plan with 1/3 of the stock option vested on the Date of the Earliest Transaction.